FLEXIBLE FIBERSCOPE, MODEL 7331.001, GUIDE SECTION FOR LITHOVAC HANDPIECE, MODEL 8708.253

K991178 · Richard Wolf Medical Instruments Corp. · FGB · Jun 11, 1999 · Gastroenterology, Urology

Device Facts

Record IDK991178
Device NameFLEXIBLE FIBERSCOPE, MODEL 7331.001, GUIDE SECTION FOR LITHOVAC HANDPIECE, MODEL 8708.253
ApplicantRichard Wolf Medical Instruments Corp.
Product CodeFGB · Gastroenterology, Urology
Decision DateJun 11, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.1500
Device ClassClass 2
AttributesTherapeutic

Indications for Use

The flexible fiberscopes are used to examine body cavities and hollow organs via natural accesses or surgically created accesses.

Device Story

Flexible fiberscope; consists of flexible insertion part, control section, and eyepiece. Transmits images via objective lens and fiber bundle for direct visualization or video camera attachment. Features straight working channel for auxiliary instruments (lithotripsy probes, biopsy forceps, HF electrodes) and irrigation. Tip provides 130°/160° up/down articulation. Used in urology, surgery, and gynecology; operated by trained medical personnel in clinical settings. Requires placement via guide wire for uretero-renoscopy or choledochus revisions. Provides visualization and access for diagnostic/therapeutic procedures; benefits patient by enabling minimally invasive internal examination and intervention.

Clinical Evidence

No clinical tests performed. Bench testing only.

Technological Characteristics

Flexible endoscope with 130°/160° tip articulation. Components: flexible insertion tube, control handle, eyepiece, and straight working channel. Materials include fiber bundles for image transmission. Supports connection to light sources, cameras, suction/irrigation, and auxiliary instruments. Compatible with gas sterilization. No software or electronic processing components.

Indications for Use

Indicated for examination, diagnosis, and therapy in urology, surgery, and gynecology. Used with endoscopic accessories and auxiliary instruments (e.g., lithotripsy probes, forceps, HF instruments) via the instrument's working channel. Excludes applications to the heart and circulatory systems. For use by adequately trained medical personnel.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

In combination with the general controls of the FD&C Act, the integrated operating table-electromechanical surgical system is subject to the following special controls: 1. (1) Premarket clinical performance testing, or a combination of premarket clinical performance testing and postmarket surveillance (in accordance with special control (2)), must include the following: 1. (i) Objective performance measures (e.g., rate and number of conversions to other surgical modalities, rate of device related adverse events (including tissue injury, hematoma, and increased blood loss), and their severity, cause, and outcomes) must be reported with relevant descriptive comparator performance measures. 2. (ii) The data must demonstrate the performance of the device for providing accurate and precise control of attached surgical instruments in range of clinical conditions relevant to the device's intended use. 3. (iii) The test dataset must include data collected from a patient population representative of the intended patient population under anticipated conditions of use. 2. (2) Data obtained from postmarket surveillance must demonstrate, in consideration of the premarket data obtained in accordance with special control (1), that the device performs in accordance with special control (1), unless FDA determines, based on the totality of the premarket data, that data from postmarket surveillance is not required to demonstrate that the device performs as intended. Such postmarket surveillance must be conducted per a protocol determined appropriate by FDA to demonstrate that the device performs as intended (in consideration of the premarket data obtained in accordance with special control (1)), and must include initiation, enrollment, and reporting requirements to ensure timely periodic updates to FDA on post-market surveillance progress and outcomes. 3. (3) Animal performance testing must evaluate the extent of port site trauma due to repositioning of table during surgical procedures when utilizing robotic minimally invasive and laparoscopic approaches 4. (4) The device manufacturer must develop, and update as necessary, a device-specific use training program that ensures proper device setup/use/shutdown, accurate control of instruments to perform the intended surgical procedures, troubleshooting and handling during unexpected events or emergencies, and safe practices to mitigate use error. 5. (5) The device manufacturer may only distribute the device to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program. (6) Human factors assessment must demonstrate that the user can correctly use the device system across all intended use environments with the provided instructions and training materials, including patient access during normal operating conditions and emergency situations, and effects arising from the integrated nature of the operating table and robotic surgical arms. (7) Labeling must include: (i) A detailed summary of clinical performance testing conducted with the device, including study population, results, adverse events, and comparisons to any comparator groups identified; (ii) A statement in the labeling that the safety and effectiveness for the representative specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of the patient's underlying disease or condition, unless FDA determines that it can be removed or modified based on clinical performance data submitted to FDA; (iii) Identification of compatible devices; (iv) The list of surgical procedures for which the device has been determined to be safe with clinical justification; (v) Reprocessing instructions for reusable components; (vi) A shelf life for any sterile components; (vii) A description of the device-specific use training program; (viii) A statement that the device is only for distribution to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program; and (ix) A summary of any completed postmarket surveillance data collected as required by special control (2), including updated labeling to accurately reflect outcomes observed in postmarket surveillance. (8) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and must include: (i) Device motion accuracy and repeatability; (ii) System testing; (iii) Instrument reliability; (iv) Crosstalk; (v) Table motion control; (vi) Thermal effects on tissue; (vii) User-device interface performance; (viii) Workspace access testing; and (ix) Performance testing with compatible devices. (9) Software verification, validation, and hazard analysis must be performed. (10) Electromagnetic compatibility and electrical, thermal, and mechanical safety testing must be performed. (11) Performance data must demonstrate the sterility of all patient-contacting device components. (12) Performance data must support the shelf life of the device components provided sterile by demonstrating continued sterility and package integrity over the labeled shelf life. (13) Performance data must validate the reprocessing instructions for the reusable components of the device. (14) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (15) Performance data must demonstrate that all patient-contacting components of the device are non-pyrogenic. (16) The device manufacturer must submit a report to the FDA annually on the anniversary of initial marketing authorization for the device, until such time as FDA may terminate such reporting, which comprises the following information: (i) Cumulative summary, by year, of complaints and adverse events since date of initial marketing authorization; and (ii) Identification and rationale for changes made to the device, labeling, or device specific use training program, which did not require submission of a premarket notification during the reporting period.

Predicate Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of a bird or eagle with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the bird image. The text is in all capital letters and is evenly spaced around the circle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Richard Wolf Medical Instruments Corporation Mr. Robert L. Casarsa Quality Assurance Manager 353 Corporate Woods Parkway Vernon Hills, IL 60061 ## JUL 2 7 2015 K991178 Re: Trade/Device Name: Flexible Fiberscope Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: FGB Dated (Date on orig SE ltr): April 5, 1999 Received (Date on orig SE ltr): April 7, 1999 Dear Mr. Casarsa, This letter corrects our substantially equivalent letter of June 11, 1999. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be {1}------------------------------------------------ Page 2 - found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Benjamin R. Fisher -S Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ \$\rho_{gi} \propto r\$ 9911 78 510(k) Number (if known):_ Device Name: Flexible Fiberscope ## Intended Use: The flexible fiberscopes are used to examine body cavities and hollow organs via natural accesses or surgically created accesses. ## Indications and Field of Application: dications and Field of Application. For examination, diagnosis, and / or therapy in connection with endoscopic accessories and For examination, diagnosis, and / Officialpy in corporal flexible lithoripsy probes, e.g., auxiliary instruments, in particular, for intracorporal of the instrument auxiliary instruments, in particular, for intraces poraring channel of the instrument. The instruments are used in the medical disciplines of urology, surgery, gynecology, and The instruments are used in the medical personnel. Applications to the heart, the heart, the ENT by adequately trained a the circulatory systems are excluded. Important! Product dimensions must correspond to the anatomic requirements, i.e., use the flexible fiberscope appropriate to the medical discipline. (PLEASE DO NOT WRITE EELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH Office of Device Evaluation (ODE) (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number: K991178 Prescription Use Per 21 CRF 801.109 OR 5 - 1 Over-The Counter_ {3}------------------------------------------------ ## Contraindications: K99 "78 ff 206 r Contraindications directly related to the product are currently unknown. Based on the patient's general condition, the attending physician must determine if the application is appropriate. For further information refer to the latest medical literature. ## Combinations: The flexible fiberscopes are used in combination with light sources and flexible light cables, video cameras, or reflex cameras and lenses/objectives, suction irrigation devices, as well as endoscopic accessories (flexible lithotripsy probes, forceps, HF instruments, sheaths laser fibers, etc.). Caution! Ensure devices used in combination are compatible n their intended use and relevant specifications, e.g., working length, diameter, etc. Comply with the device instruction manuals used in combination with the submitted devices. Important! If the fiberscopes are used as uretero-renoscopes or in choledochus revisions, they must be placed via a guide wire. ### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH Office of Device Evaluation (ODE) | (Division Sign-Off) | | |--------------------------------------------------------------------|---------| | Division of Reproductive, Abdominal, ENT, and Radiological Devices | | | 510(k) Number | K991178 | | Prescription Use | OR Over-The Counter | |--------------------|------------------------| | Per 21 CRF 801 109 | 5-2 | {4}------------------------------------------------ ■ i 491178 Pg. 1 of r 355 Corporate Woods Parkway Vernon Hills, Illinous 60064 Phone: 847.913.1443 Fax: \$47.913.1488 ## RICHARD WOL MEDICAL INSTRUMENTS CORPORAT ## 510(k) Summary of Safety and Effectiveness | Submitter: | | |------------|--| |------------|--| | Company / Institution name: | Richard Wolf Medical Instruments Corp. | |--------------------------------|----------------------------------------| | Division name (if applicable): | N.A. | | Street address: | 353 Corporate Woods Parkway | | City: | Vernon Hills | | State/Province: | Illinois | | Country: | USA | | ZIP/Postal Code: | 60061 | | Contact name: | Mr. Robert L. Casarsa | | Contact title: | Quality Assurance Manager | | Date of Preparation | April 5, 1999 | |--------------------------------------|----------------| | FDA establishment regulation number: | 14 184 79 | | Phone number (include area code): | (847) 913-1113 | | FAX number (include area code): | (847) 913-0924 | | Product Information: | | |----------------------|--| |----------------------|--| | Trade name: | Flexible Fiberscope | |----------------------|----------------------| | Model number: | 7331.001 | | Common name: | Flexible Fiberscopes | | Classification Name: | Flexible Endoscopes | | Information on devices to which substantial equivalence is claimed: | | |---------------------------------------------------------------------|--| |---------------------------------------------------------------------|--| | 510(k) Number | Trade or proprietary or model name | Manufacturer | |---------------|----------------------------------------------------------------------|----------------| | 1 K980401 | 1 Flexible Fiberscopes | 1 Richard Wolf | | 2 K963855 | 2 Compact Operating Ureteroscopes & Uretero-Renoscopes Devices (URS) | 2 Richard Wolf | | 3 | 3 | 3 | | 4 | 4 | 4 | | 5 | 5 | 5 | | 6 | 6 | 6 | ### 1.0 Description The flexible fiberscopes consist of a flexible insertion part, a control part, a bent eyepiece for direct view or connection of a video camera and straight working channel, especially for the use with lithotripsy probes. ਰੋ {5}------------------------------------------------ 用 K991175 pg.29r ### 2.0 Intended Use The flexible fiberscopes are used to examine body cavities and hollow organs via natural accesses or surgically created accesses. ### 3.0 Technological Characteristics There are no significant technological characteristic changes to the new devices when compared to the existing devices. The tip of the sheath has an active 130° / 160° up/down. The image is transmitted via objective, fiber bendle and eyepiece for direct view or connection of a video camera. The straight working channel is used for procedures such as lithotripsy and biopsy removal while simultaneously providing irrigation. The bent eyepiece funnel can be moved to the right or left. Auxiliary instruments, such as gaping forceps, sone extractors, or HF button electrodes are inserted by a proximal mounted insertion cock with supply and discharge. A leakage test unit or a gas sterilization valve can be connected to an attachment of the fiberscope. ### Substantial Equivalence 4.0 The submitted devices pose the same type of questions about safety and effectiveness as the compared devices. The new technological characteristics have not diminished safety or effectiveness. The submitted devices are substantially equivalent to existing pre-enactment and 510(k) devices sold by Richard Wolf (K980401, K963855). ### 5.0 Performance Data No known FDA performance standard exists. ### 6.0 Clinical Tests No clinical tests performed. ### 7.0 Conclusions Drawn These devices are designed and tested to guarantee the safety and effectiveness when used according to the instruction manual. By: Robert L. Casarsa **Date:** Mac 31 99 Quality Assurance Manager
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...